Sclerotherapy: Indications and safety volumes
- PMID: 37899570
- PMCID: PMC10877989
- DOI: 10.1177/02683555231211092
Sclerotherapy: Indications and safety volumes
Keywords: chronic venous disease; foam sclerotherapy; guideline; sclerotherapy.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Myers K. A history of injection treatments–II sclerotherapy. Phlebology 2019; 34(5): 303–310. - PubMed
-
- Rabe E, Pannier F, Guideline Group . Indications, contraindications and performance: European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014; 29(1_suppl): 26–33. - PubMed
-
- Rathbun S, Norris A, Morrison N, et al. Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines. Phlebology 2014; 29(2): 76–82. - PubMed
-
- Wong M, Parsi K, Myers K, et al. Sclerotherapy of lower limb veins: indications, contraindications and treatment strategies to prevent complications–A consensus document of the International Union of Phlebology-2023. Phlebology 2023; 14: 02683555231151350. - PubMed
-
- Davies HO, Popplewell M, Darvall K, et al. A review of randomised controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology 2016; 31(4): 234–240. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
